US 12221462
Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12221462 (Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells) held by Allogene Therapeutics, Inc. expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K2239/23